moxalactam has been researched along with tobramycin in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 49 (87.50) | 18.7374 |
| 1990's | 3 (5.36) | 18.2507 |
| 2000's | 3 (5.36) | 29.6817 |
| 2010's | 1 (1.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
| Ito, M; Kojima, R; Suzuki, Y | 6 |
| Chastagner, P; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C; Tancrede, C | 1 |
| Chimura, T; Hirayama, T; Ogawa, T; Shiina, Y | 1 |
| Boughton, BJ; Brown, RM; Harris, RI; Perry, DJ; Rhodes, EG; Welch, RS | 1 |
| Blaise, D; Carcassonne, Y; Gaspard, MH; Mannoni, P; Maraninchi, D; Miquel, M; Stoppa, AM; Viens, P | 1 |
| Elliott, CR; Pater, JL | 1 |
| Ishida, M; Kawamura, K; Onodera, K; Takanashi, S; Takekawa, H | 1 |
| Danziger, LH; Ferron, JL; Gauderer, MW; Gordon, N; Hau, T; Stellato, TA | 1 |
| Bow, EJ; Louie, TJ | 1 |
| Aldridge, KE; Faro, S; Nicaud, SK; Pastorek, JG | 1 |
| Apicella, MA; Morse, GD; Walshe, JJ | 1 |
| Caplan, ES; Fitzpatrick, BJ; Joshi, M; Tenney, JH; Warren, JW | 1 |
| Abe, Y; Banzai, M; Chimura, T; Ito, K; Kanasugi, H; Nakakuki, M; Sato, S; Sumiyoshi, Y; Suzuki, T | 1 |
| Barza, M; Gorbach, SL; Ho, JL; Kellum, JM; O'Donnell, TF; Tally, FP | 1 |
| Bezwoda, WR; Cassel, R; Derman, DP; Perkins, S | 1 |
| Sabath, LD; Tack, KJ | 1 |
| Belch, A; Bow, EJ; Chow, A; Feld, R; Louie, TJ; Mandell, L; Miedzinski, L; Pater, J; Rachlis, A; Robson, HG | 1 |
| Landers, DV; Ohm-Smith, M; Robbie, MO; Sweet, RL | 1 |
| Benitez, PR; Nelson, RM; Newell, MA; Wilson, RF | 1 |
| Baxter, JG; Marble, DA; Schentag, JJ; Walczak, P; Wels, PB; Whitfield, LR | 1 |
| Barriere, SL; Earp, CM | 1 |
| Bakken, JS; Hulsund, M | 1 |
| Rahman, M | 1 |
| Cohn, DL; Reimer, LG; Reller, LB | 1 |
| Cynamon, MH; Granato, PA | 1 |
| Johnson, CE; Pennington, JE; Platt, R | 1 |
| Abbruzzese, JL; Laskin, OL; Lipsky, JJ; McGaughey, MD; Rocco, LE; Skubitz, KM | 1 |
| Carson, HB; Heller, AS; Koch, TB; Schentag, JJ; Walczak, P | 1 |
| Lascola, RJ; Reitberg, DP; Schentag, JJ; Van Tyle, JH; Walczak, P; Wels, PB | 1 |
| Fitzpatrick, SB; Rosenstein, BJ | 1 |
| Klastersky, J; Lagast, H; Zinner, SH | 1 |
| Drew, WL; Mintz, L | 1 |
| Alanis, A; Rehm, S; Weinstein, AJ | 1 |
| Bow, EJ; Chubb, H; Conly, JM; Louie, TJ; Ramotar, K | 1 |
| Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
| Ericsson, CD; Rowlands, BJ | 1 |
| Creger, RJ; Falkowski, AJ | 1 |
| Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 1 |
| Mirrett, S; Reimer, LG; Reller, LB | 1 |
| Butler, TF; Mahoney, DF; Turner, JR | 1 |
| Harada, Y; Okamoto, T; Teshima, K | 1 |
| Goldner, M; Scudamore, RA | 1 |
| Hardy, BG; Heller, AS; Schentag, JJ; Wels, PB | 1 |
| Schentag, JJ | 1 |
| Aronoff, GR; Brier, ME; Nierste, DM; Sloan, RS | 1 |
| Jouenne, T; Junter, GA; Tresse, O | 1 |
1 review(s) available for moxalactam and tobramycin
| Article | Year |
|---|---|
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
19 trial(s) available for moxalactam and tobramycin
| Article | Year |
|---|---|
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.
Topics: Agranulocytosis; Bacterial Infections; Drug Therapy, Combination; Fever; Humans; Immune Tolerance; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Moxalactam; Neutropenia; Prothrombin Time; Random Allocation; Tobramycin | 1987 |
[Randomized trial of empirical antibiotic therapy in febrile episodes after bone marrow transplantation. Comparison of an aminoglycoside-beta lactam (tobramycin-ticarcillin) combination with 2 beta-lactam antibiotics (ticarcillin-latamoxef)].
Topics: Adolescent; Adult; Bacterial Infections; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Moxalactam; Penicillins; Postoperative Complications; Random Allocation; Sepsis; Ticarcillin; Tobramycin | 1988 |
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Clinical Trials as Topic; Cloxacillin; Drug Therapy, Combination; Fever; Humans; Infection Control; Leukemia; Lymphoma; Moxalactam; Multicenter Studies as Topic; Neoplasms; Neutropenia; Prognosis; Random Allocation; Tobramycin | 1988 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.
Topics: Agranulocytosis; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Humans; Moxalactam; Mycoses; Ticarcillin; Tobramycin | 1987 |
Moxalactam versus clindamycin plus tobramycin for the treatment of puerperal infections.
Topics: Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Humans; Moxalactam; Pregnancy; Prospective Studies; Puerperal Infection; Random Allocation; Tobramycin | 1987 |
A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
Topics: Bacterial Infections; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Tobramycin | 1986 |
Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Surgical Wound Infection; Tobramycin | 1986 |
Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Random Allocation; Tobramycin | 1985 |
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Canada; Clinical Trials as Topic; Drug Therapy, Combination; Female; Granulocytes; Humans; Leukemia; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Penicillin Resistance; Prognosis; Random Allocation; Ticarcillin; Tobramycin | 1985 |
Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
Topics: Adolescent; Adult; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Middle Aged; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Random Allocation; Tobramycin | 1985 |
Single-antibiotic use for penetrating abdominal trauma.
Topics: Abdominal Injuries; Blood Coagulation; Clindamycin; Colon; Drug Therapy, Combination; Humans; Moxalactam; Postoperative Care; Premedication; Prospective Studies; Random Allocation; Tobramycin; Wound Infection; Wounds, Penetrating | 1986 |
Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.
Topics: Abdomen; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Clindamycin; Drug Combinations; Female; Hemorrhage; Humans; Infections; Male; Middle Aged; Moxalactam; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time; Random Allocation; Risk; Tobramycin; Vitamin K | 1985 |
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clinical Trials as Topic; Double-Blind Method; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Streptococcal Infections; Tobramycin; Urinary Tract Infections | 1983 |
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.
Topics: Abdomen; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infections; Male; Middle Aged; Moxalactam; Nutrition Disorders; Prognosis; Random Allocation; Staphylococcal Infections; Staphylococcus; Tobramycin | 1983 |
Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
Topics: Agranulocytosis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Infections; Male; Moxalactam; Nafcillin; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Drug Therapy, Combination; Escherichia coli; Feces; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Intestines; Moxalactam; Neoplasms; Neutropenia; Prothrombin Time; Ticarcillin; Tobramycin | 1984 |
Comparative studies of antibiotic therapy after penetrating abdominal trauma.
Topics: Abdominal Injuries; Adolescent; Cefoxitin; Cephalosporins; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation; Time Factors; Tobramycin; Wound Infection; Wounds, Gunshot; Wounds, Stab | 1984 |
37 other study(ies) available for moxalactam and tobramycin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (6): A mechanism for the suppressive action of latamoxef on intrarenal tobramycin level.
Topics: Animals; Anti-Bacterial Agents; In Vitro Techniques; Kidney; Kidney Diseases; Male; Moxalactam; Rats; Rats, Inbred Strains; Tobramycin | 1990 |
Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (7): Effect of latamoxef on binding of tobramycin to brush border membranes isolated from rat kidney cortex.
Topics: Animals; Anti-Bacterial Agents; Kidney Cortex; Kidney Diseases; Male; Membranes; Microscopy, Electron; Microvilli; Moxalactam; Rats; Rats, Inbred Strains; Tobramycin | 1989 |
Role of parenteral antibiotherapy in gastrointestinal tract flora suppression. A study in children treated with high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adolescent; Agranulocytosis; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Digestive System; Dose-Response Relationship, Drug; Drug Combinations; Feces; Female; Gentamicins; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Male; Mezlocillin; Moxalactam; Sulfamethizole; Suppression, Genetic; Tobramycin; Transplantation, Autologous; Trimethoprim | 1989 |
[Effects of prophylactically used latamoxef with tobramycin against postoperative infections on therapeutic drug monitoring and renal function in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; Cesarean Section; Drug Therapy, Combination; Drug Tolerance; Female; Genital Diseases, Female; Humans; Hysterectomy; Infusions, Intravenous; Kidney; Kidney Function Tests; Middle Aged; Moxalactam; Postoperative Complications; Pregnancy; Pregnancy Complications; Premedication; Tobramycin | 1989 |
[A case of pneumonitis due to latamoxef and tobramycin].
Topics: Aged; Humans; Lung; Lymphocyte Activation; Male; Moxalactam; Pulmonary Fibrosis; Radiography; Tobramycin | 1988 |
Absorption of intraperitoneal antibiotics.
Topics: Absorption; Anti-Bacterial Agents; Cefamandole; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Moxalactam; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Radioimmunoassay; Tobramycin; Vancomycin | 1988 |
Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects. (5). Interaction of tobramycin with latamoxef in vitro.
Topics: Animals; Anti-Bacterial Agents; Chromatography, Thin Layer; Drug Interactions; Electrophoresis, Paper; Kidney; Male; Moxalactam; Rats; Rats, Inbred Strains; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tobramycin | 1988 |
Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (4). Effects of tobramycin alone and in combination with latamoxef on the stability of rat kidney lysosomal membranes.
Topics: Acetylglucosaminidase; Acid Phosphatase; Aminoglycosides; Animals; Anti-Bacterial Agents; In Vitro Techniques; Intracellular Membranes; Kidney Diseases; Lysosomes; Male; Moxalactam; Proteins; Rats; Rats, Inbred Strains; Tobramycin | 1987 |
[Prophylactic effects of a combined use of a cephem antibiotic, latamoxef, and tobramycin on postoperative infection in obstetrics and gynecology].
Topics: Adult; Cesarean Section; Drug Therapy, Combination; Female; Humans; Hysterectomy; Injections, Intravenous; Middle Aged; Moxalactam; Pregnancy; Surgical Wound Infection; Tobramycin | 1987 |
Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (3). Protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism.
Topics: Acetylglucosaminidase; Aminoglycosides; Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Kidney; Kidney Diseases; L-Lactate Dehydrogenase; Male; Moxalactam; Muramidase; Proteinuria; Rats; Rats, Inbred Strains; Tobramycin | 1986 |
Protective effect of latamoxef on aminoglycoside nephrotoxicity in rats.
Topics: Acetylglucosaminidase; Animals; Kidney; Male; Moxalactam; Rats; Rats, Inbred Strains; Tobramycin | 1986 |
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
Topics: Amikacin; Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Salmonella; Serratia; Staphylococcus; Streptococcus; Tobramycin | 1985 |
The lack of inactivation of tobramycin by cefazolin, cefamandole, and moxalactam in vitro.
Topics: Cefamandole; Cefazolin; Drug Stability; Humans; In Vitro Techniques; Moxalactam; Temperature; Time Factors; Tobramycin | 1985 |
New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Humans; Moxalactam; Tobramycin | 1984 |
Activities of two aminoglycosides and five newer beta-lactam antibiotics: safer alternatives to aminoglycosides?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Humans; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Tobramycin | 1984 |
Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.
Topics: Anti-Bacterial Agents; Bacteria; Cephalothin; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Sepsis; Tobramycin | 1982 |
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Tobramycin | 1982 |
Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
Topics: Animals; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Guinea Pigs; Moxalactam; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin | 1982 |
Antibiotic penetration in abdominal infection: a case of tobramycin failure responsive to moxalactam.
Topics: Abdomen; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Middle Aged; Moxalactam; Postoperative Complications; Tobramycin | 1983 |
Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Male; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 1983 |
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Culture Media; Humans; Injections, Intravenous; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1981 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |
Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
Topics: Azlocillin; Carbenicillin; Cefamandole; Drug Interactions; Humans; Hydroxylamine; Hydroxylamines; Immunoenzyme Techniques; In Vitro Techniques; Moxalactam; Penicillins; Piperacillin; Ticarcillin; Tobramycin | 1984 |
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefamandole; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Tobramycin | 1980 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
Procedure for assay of tobramycin in serum containing moxalactam.
Topics: Anti-Bacterial Agents; Bacillus cereus; Bacillus subtilis; Biological Assay; Cephalosporinase; Cephalosporins; Cephamycins; Humans; Hydrolysis; Moxalactam; Tobramycin; Zinc | 1981 |
[Comparative nephrotoxicity of latamoxef and other cephalosporins in rabbits. Combined administration with furosemide or tobramycin. (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Blood Chemical Analysis; Cephalosporins; Cephamycins; Drug Synergism; Furosemide; Kidney; Kidney Diseases; Liver; Male; Moxalactam; Organ Size; Rabbits; Tobramycin | 1981 |
Limited contribution of the outer-membrane penetration barrier towards intrinsic antibiotic resistance of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cell Membrane Permeability; Cephamycins; Edetic Acid; Erythromycin; Gentamicins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1982 |
Antibiotic penetration in liver infection: a case of tobramycin failure responsive to moxalactam.
Topics: Adult; Athletic Injuries; Bilirubin; Creatinine; Enterobacter; Enterobacteriaceae Infections; Humans; Liver; Liver Diseases; Male; Moxalactam; Time Factors; Tissue Distribution; Tobramycin; Wounds, Nonpenetrating | 1983 |
Specificity of renal tubular damage criteria for aminoglycoside nephrotoxicity in critically ill patients.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Critical Care; Female; Gentamicins; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Tubules; Kinetics; Male; Middle Aged; Moxalactam; Tobramycin | 1983 |
Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function.
Topics: Anuria; Drug Interactions; Humans; Kinetics; Male; Moxalactam; Tobramycin | 1984 |
The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and beta-lactam antibiotics.
Topics: Agar; Anti-Bacterial Agents; Biofilms; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Moxalactam; Oxygen; Tobramycin | 1995 |